These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6702724)

  • 1. The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2).
    Girolami A; Ruzza G; Saggin L; Sticchi A; Melizzi R
    Am J Clin Pathol; 1984 Mar; 81(3):323-8. PubMed ID: 6702724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between normal antithrombin III and antithrombin III Padua as determined by laser nephelometry.
    Girolami A; Saggin L; Sticchi A; Ruffato G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):895-900. PubMed ID: 6187642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin evaluation as obtained by kinetics studies of antigen-antibody reaction in a laser nephelometer.
    Girolami A; Sticchi A; Melizzi R; Saggin L; Ruzza G
    Thromb Haemost; 1984 Aug; 52(1):15-8. PubMed ID: 6495258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
    Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
    Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin.
    Girolami A; Marafioti F; Rubertelli M; Vicarioto MA; Cappellato G; Mazzuccato M
    Acta Haematol; 1984; 72(2):73-82. PubMed ID: 6208738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser nephelometer evaluation of factor IX.
    Ruzza G; Lazzaro AR; Viero ML; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):843-9. PubMed ID: 1713891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
    Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system.
    Girolami A; Cappellato G; Vicarioto MA; Vergolani A; Traverso R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):159-64. PubMed ID: 2581861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III determination by rate (kinetic) nephelometry.
    Balla G; Misz M; Karmazsin L; Rák K
    Thromb Haemost; 1984 Feb; 51(1):9-11. PubMed ID: 6426081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer].
    Hopmeier P; Heuss F; Fischer M
    Wien Klin Wochenschr; 1984 Dec; 96(24):881-4. PubMed ID: 6528618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against antithrombin III and their application in an immunoradiometric assay.
    Watton J; Baines M; Barrowcliffe TW
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):619-26. PubMed ID: 2133241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of heparin activity by a new laser nephelometric method and comparison to the USP method.
    Escobar A; Maher RT; Courtney ML; Valicenti AJ
    J Pharm Sci; 1984 Nov; 73(11):1640-2. PubMed ID: 6520771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser nephelometric quantitation of antithrombin-III (AT-III) development of a new assay.
    Parvez Z; Fareed J; Messmore HL; Moncada R
    Thromb Res; 1981 Dec 1-15; 24(5-6):367-77. PubMed ID: 6806931
    [No Abstract]   [Full Text] [Related]  

  • 18. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
    Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.